These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35852930)

  • 21. Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
    Bayle A; Baldini C; Martin-Romano P; Michot JM; Champiat S; Bahleda R; Gazzah A; Marabelle A; Verlingue L; Geraud A; Morel D; Michiels S; Hollebecque A; Albiges L; Besse B; Soria JC; Massard C; Barlesi F; Postel-Vinay S
    Cancer Cell; 2021 Aug; 39(8):1039-1041. PubMed ID: 34197735
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial.
    Ashraf S; Ashraf S; Ashraf M; Farooq I; Akmal R; Imran MA; Kalsoom L; Ashraf S; Rafique S; Ghufran M; Akram MK; Sohaib-Ur-Rehman ; Nadeem MF; Matti N; Siddiqui UN; Humayun A; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Trials; 2022 Jan; 23(1):58. PubMed ID: 35045888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.
    Jones CW; Woodford AL; Platts-Mills TF
    BMJ Open; 2020 Sep; 10(9):e041276. PubMed ID: 32948577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
    van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
    BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.
    Graetz D; Agulnik A; Ranadive R; Vedaraju Y; Chen Y; Chantada G; Metzger ML; Mukkada S; Force LM; Friedrich P; Lam C; Sniderman E; Bhakta N; Hessissen L; Dalvi R; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Moreira DC
    Lancet Child Adolesc Health; 2021 May; 5(5):332-340. PubMed ID: 33675698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
    Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
    Bakouny Z; Labaki C; Bhalla S; Schmidt AL; Steinharter JA; Cocco J; Tremblay DA; Awad MM; Kessler A; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang H; Anderson-Keightly HM; El Zarif T; Alaiwi SA; Champagne C; Rosenbloom TD; Stewart PS; Johnson BE; Trinh Q; Tolaney SM; Galsky MD; Choueiri TK; Doroshow DB
    Ann Oncol; 2022 Aug; 33(8):836-844. PubMed ID: 35715285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychological health of patients diagnosed with cancer in Iraq during the COVID-19 pandemic: A single center study.
    Alrubai T; Khalil AM; Zaki R; Sinno L; Al Tabbah S
    Psychooncology; 2022 Apr; 31(4):649-660. PubMed ID: 34751985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
    Gheorghe AS; Negru ŞM; Nițipir C; Mazilu L; Marinca M; Gafton B; Ciuleanu TE; Schenker M; Dragomir RD; Gheorghe AD; Stovicek PO; Bandi-Vasilica M; Boț AC; Mihăilă RI; Zob DL; Kajanto AL; Stănculeanu DL
    ESMO Open; 2021 Feb; 6(1):100027. PubMed ID: 33399089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.